BeStock  
Stocks › Biotechnology › GERN

Geron GERN

US equityMarket cap rank #3434Biotechnology
$1.20 −$0.01 (-0.83%)
Pre-market · Oct 8, 8:50 am ET · After hours $1.20 0.00%
Open$1.21
Prev close$1.21
Day range$1.19 – $1.22
Volume5.14M
Market cap$770.97M
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±8.0%last 16 reports
Closed higher5 of 1631% of the time
Best reaction+21.6%
Worst reaction-32.1%

Stock move on the day after each report

-7.8%2023/Q3-5.6%2023/Q4-3.2%2024/Q1+0.9%2024/Q2+0.5%2024/Q3-32.1%2024/Q4-0.8%2025/Q1+15.8%2025/Q2-5.2%2025/Q3-11.8%2025/Q4-4.2%2026/Q1+21.6%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q25 Aug 2026Pre Market±37.2%+21.64%Within range
2026/Q16 May 2026Pre Market±15.2%-4.24%Within range
2025/Q425 Feb 2026Pre Market±25.6%-11.79%Within range
2025/Q35 Nov 2025Pre Market–-5.22%–
2025/Q26 Aug 2025Pre Market±29.2%+15.83%Within range
2025/Q17 May 2025Pre Market±30.0%-0.76%Within range
2024/Q426 Feb 2025Pre Market±33.5%-32.07%Within range
2024/Q37 Nov 2024Pre Market±15.9%+0.47%Within range
2024/Q28 Aug 2024Pre Market±13.5%+0.88%Within range
2024/Q12 May 2024Pre Market±14.4%-3.19%Within range
2023/Q428 Feb 2024Pre Market±47.1%-5.57%Within range
2023/Q32 Nov 2023Pre Market±18.8%-7.77%Within range
2023/Q23 Aug 2023After Market±16.6%-6.33%Within range
2023/Q111 May 2023Pre Market±19.1%+2.48%Within range
2022/Q416 Mar 2023After Market±21.1%-4.53%Within range
2022/Q33 Nov 2022Pre Market±18.6%-5.58%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q2, ended Jun 2026

Revenue$57.48M+17.2% YoY
Operating profit-$12.65M-1.6% YoY
Net profit-$16.68M-1.9% YoY
Diluted EPS-$0.02+0.0% YoY
Free cash flow-$16.05M+41.7% YoY
Operating cash flow-$15.83M

Revenue, last 8 quarters

$28.3MSep '24$47.5MDec '24$39.6MMar '25$49.0MJun '25$47.2MSep '25$48.0MDec '25$51.8MMar '26$57.5MJun '26

Net profit, last 8 quarters

$-26.4MSep '24$-25.4MDec '24$-19.8MMar '25$-16.4MJun '25$-18.4MSep '25$-28.9MDec '25$-3.6MMar '26$-16.7MJun '26

Profitability & balance sheet

Gross margin93.5%
Operating margin-17.2%
Net margin-33.1%
Return on equity-28.3%
Return on assets-12.6%
Return on invested capital-14.4%
Current ratio6.92
Liabilities / assets57.9%
Cash & investments$300.85M
Total debt$121.13M
Net cash (debt)$179.72M

Discussion

No comments yet — be the first to weigh in on GERN.

Leave a comment

Scroll to Top